156 related articles for article (PubMed ID: 20036363)
1. Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): a follow-up study.
Dohi T; Miyauchi K; Okazaki S; Yokoyama T; Yanagisawa N; Tamura H; Kojima T; Yokoyama K; Kurata T; Daida H
Atherosclerosis; 2010 Jun; 210(2):497-502. PubMed ID: 20036363
[TBL] [Abstract][Full Text] [Related]
2. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
[TBL] [Abstract][Full Text] [Related]
3. Higher baseline LDL-C levels amplify the short-term benefit of early intensive statin treatment in acute coronary syndrome.
Dohi T; Miyauchi K; Okazaki S; Yokoyama T; Yanagisawa N; Tamura H; Kojima T; Yokoyama K; Kurata T; Daida H
J Atheroscler Thromb; 2011; 18(1):42-8. PubMed ID: 20972351
[TBL] [Abstract][Full Text] [Related]
4. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
[TBL] [Abstract][Full Text] [Related]
5. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.
Ray KK; Cannon CP; McCabe CH; Cairns R; Tonkin AM; Sacks FM; Jackson G; Braunwald E;
J Am Coll Cardiol; 2005 Oct; 46(8):1405-10. PubMed ID: 16226162
[TBL] [Abstract][Full Text] [Related]
6. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
Chyrchel M; Rakowski T; Rzeszutko L; Legutko J; Dziewierz A; Dubiel JS; Dudek D
Kardiol Pol; 2006 Dec; 64(12):1357-62; discussion 1363. PubMed ID: 17206539
[TBL] [Abstract][Full Text] [Related]
7. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
[TBL] [Abstract][Full Text] [Related]
8. Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study.
Ohashi T; Shibata R; Morimoto T; Kanashiro M; Ishii H; Ichimiya S; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura T; Daida H; Murohara T; Matsuzaki M
Atherosclerosis; 2010 Sep; 212(1):237-42. PubMed ID: 20684825
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
Zhao SP; Peng DQ; Yu BL; Huo Y;
Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
[TBL] [Abstract][Full Text] [Related]
10. More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study.
Arai H; Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
J Atheroscler Thromb; 2010 Oct; 17(10):1096-107. PubMed ID: 20675955
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Navarese EP; Kowalewski M; Andreotti F; van Wely M; Camaro C; Kolodziejczak M; Gorny B; Wirianta J; Kubica J; Kelm M; de Boer MJ; Suryapranata H
Am J Cardiol; 2014 May; 113(10):1753-64. PubMed ID: 24792742
[TBL] [Abstract][Full Text] [Related]
12. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026
[TBL] [Abstract][Full Text] [Related]
13. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of switching from intensive to moderate statin therapy after acute coronary syndromes.
Colivicchi F; Tubaro M; Santini M
Int J Cardiol; 2011 Oct; 152(1):56-60. PubMed ID: 20674999
[TBL] [Abstract][Full Text] [Related]
15. Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention.
Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovičová L; Tomašov P; Tesař D
Am J Cardiol; 2011 May; 107(9):1295-9. PubMed ID: 21349484
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.
Di Sciascio G; Patti G; Pasceri V; Gaspardone A; Colonna G; Montinaro A
J Am Coll Cardiol; 2009 Aug; 54(6):558-65. PubMed ID: 19643320
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
Patti G; Pasceri V; Colonna G; Miglionico M; Fischetti D; Sardella G; Montinaro A; Di Sciascio G
J Am Coll Cardiol; 2007 Mar; 49(12):1272-8. PubMed ID: 17394957
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after statin treatment in routine clinical practice: results from a prospective PCI cohort study.
Eindhoven JA; Onuma Y; Oemrawsingh RM; Daemen J; van Nierop JW; de Jaegere PP; Boersma E; Serruys PW; van Domburg RT
EuroIntervention; 2012 Apr; 7(12):1420-7. PubMed ID: 22522553
[TBL] [Abstract][Full Text] [Related]
20. Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.
Miyauchi K; Daida H; Morimoto T; Hiro T; Kimura T; Nakagawa Y; Yamagishi M; Ozaki Y; Kadota K; Kimura K; Hirayama A; Kimura K; Hasegawa Y; Uchiyama S; Matsuzaki M;
Circ J; 2012; 76(4):825-32. PubMed ID: 22451449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
